Opportunities lie in the launch of advanced autoinjectors with smart technology and favorable regulatory environments, ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

The U.S. does not buy drugs directly for a national health system, as countries such as England and Germany do, instead ...

Drugmakers have said they’re still unclear about whether Trump will impose tariffs on finished products or on active ...

European stocks fell to the lowest since January 2024 as the EU and China retaliated with higher tariffs on the US, ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

European firms with high US exposure face mounting risks from tariffs, recession fears, and a weakening dollar, while ...

Pharma trade lobby EFPIA, whose members include European pharma giants Bayer, Novartis and Novo Nordisk, said it had called ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...